Open Beta
TREN
MetriLume
TREN

US marketsBBNX

SEC-sourced researchBeta

BBNX

Beta Bionics, Inc.

Company comparison ↗

Data passport

CIK
0001674632
Exchange
Nasdaq
Business activity
Surgical & Medical Instruments & Apparatus · SIC 3841
Financial inputs
6/6
Filing date
Oct 7, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 65,124,000.0000 USD; December 2025: 100,251,000.0000 USD100.3M USD0 USD0December 2024December 2025
BBNX · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202465,124,000.0000Feb 24, 2026
December 2025100,251,000.0000Feb 24, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025100,251,000.0000-73,200,000.0000-50,925,000.0000328,743,000.000041,133,000.0000Feb 24, 2026
December 202465,124,000.0000-54,756,000.0000-48,273,000.0000149,645,000.000073,632,000.0000Feb 24, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

57/100
Profitability0
Growth100
Balance sheet87
Cash generation0
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$100.25MJan 1, 2025 – Dec 31, 2025Feb 24, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$65.12MJan 1, 2024 – Dec 31, 2024Feb 24, 202610-K
Net incomeNetIncomeLoss-$73.2MJan 1, 2025 – Dec 31, 2025Feb 24, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$50.93MJan 1, 2025 – Dec 31, 2025Feb 24, 202610-K
Total assetsAssets$328.74MDec 31, 2025Feb 24, 202610-K
Total liabilitiesLiabilities$41.13MDec 31, 2025Feb 24, 202610-K

New filings

Explore methodology ↗